Introduction
Preterm infants, particularly those born before 32 wk of completed gestation, are extremely vulnerable to invasive infections. Prematurity is the leading cause of death in children under 5 yr of age (;3 million neonatal deaths occur annually) and those who survive experience persistently increased morbidity that results in a considerable human and economic burden [1] [2] [3] . In addition, even those born only moderately preterm still have a persistent risk of hospitalization with infection through childhood and adolescence [4] .
Despite considerable advances in perinatal care over the past two decades, the incidence of preterm birth has increased by up to 20% in low-and middle-income countries, and almost 15 million preterm births occur annually [5, 6] . Sepsis and necrotizing enterocolitis are leading causes of mortality in neonatal intensive care units in high-income countries [7] . Preterm infants are remarkably vulnerable to neonatal sepsis, with up to one-third of extremely preterm infants developing a bloodstream infection in their first 28 d of life. Moreover, mortality rates have been reported to be as high as 30% when sepsis occurs in the first 3 d of life [7, 8] . Escherichia coli, group B Streptococcus (GBS), and Staphylococcus epidermidis are leading causes of neonatal sepsis [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] . Although there is a clear inverse relationship between gestational age (GA) and susceptibility to infection (those born earliest are most vulnerable), late-preterm infants contribute significantly to the overall burden of neonatal sepsis, as these infants make up the majority (60-70%) of preterm births [4, 21] . The consequences of infection extend beyond direct mortality, as infection-related inflammation contributes to increased risks of long-term organ dysfunction, including bronchopulmonary dysplasia and white matter brain injury [22] .
The heightened susceptibility of preterm infants to infection has been attributed to "immature" innate immune defenses and has been comprehensively reviewed [23] [24] [25] . However, increased understanding in several areas of neonatal immunity (particularly antibody responses and neutrophils) has failed to translate into effective clinical interventions. Indeed, clinical trials of i.v. polyclonal or anti-staphylococcal IgG as preventative or adjunct therapy in preterm infants has shown no significant reduction in the incidence or outcomes of sepsis caused by staphylococci or other species, or in overall mortality [26] [27] [28] [29] . Similarly, attempts to restore the numbers of circulating neutrophils in very preterm infants either through the administration of growth factors such as GM-CSF (to promote neutrophil maturation) or even granulocyte transfusions, have not reduced the incidence of neonatal sepsis or mortality caused by it [30] [31] [32] [33] .
Monocytes are at lower frequencies in peripheral blood than neutrophils, but they are critical in the defense against bacterial and fungal infections through their capacity to detect, phagocytose, and kill pathogens; orchestrate the inflammatory response through the release of chemoattractant and inflammatory cytokines; and activate the adaptive immune response [34] . Monocytes are produced early in gestation (before 20 wk) and represent 7-38% of all circulating mononuclear cells in CB of term infants [35] [36] [37] [38] . Because they are relatively abundant in blood, they are a practical cell type to study to understand innate immune functions in premature infants; however, the literature on neonatal monocytes is sparse and inconsistent. In this review, we seek to present a detailed summary of the current data on preterm infant monocyte phenotype and function and attempt to reconcile apparent discrepancies into a more unified framework (summarized in Fig. 1 ). We highlight how differences in functional and phenotypic parameters compared to term infants may contribute to susceptibility to serious infection and identify areas that warrant further research.
MONOCYTE MATURATION AND SUBSETS
Three main subsets of monocytes have been described in humans, based on their expression of the cell surface CD14, a coreceptor for the Gram-negative cell wall component LPS, and CD16 (the IgG Fc receptor FcgR-III) [39] [40, 41] . CD16 + monocytes are also expanded in neonates, children, and adults with sepsis, suggesting an active role for these cells during invasive infection [42, 43] . However, even though both nonclassic and intermediate CD16 + monocytes are closely related at a molecular level (determined by microarray gene expression profiling), the former has been shown to produce higher levels of proinflammatory cytokines (e.g., TNF-a and IL-1b) Figure 1 . A summary of the development phenotypic and functional parameters of neonatal monocytes throughout gestation. Each parameter is presented as expression levels or functionality relative to term infant monocytes, based on the literature reviewed herein. The period when infants are most at risk of sepsis is indicated by the gray box. Dashed lines represent gaps in the literature.
after LPS stimulation [44] . As implied in the name, intermediate monocytes have been proposed to represent cells in transition between classic and nonclassic monocytes and are functionally distinct with a greater capacity for antigen presentation and angiogenesis [45, 46] .
There is limited literature on the phenotype of each specific monocyte subset in neonates. Overall, preterm infants have similar proportions of total monocytes compared to term infants, but absolute blood counts correlate with increasing GA [47, 48] . The existent literature on monocyte subsets in neonates is conflicting. Two reports indicate that the intermediate monocyte subset is significantly elevated in very preterm infants (24-32 wk) compared to term infants [49, 50] , whereas another report identified similar frequencies of all three monocyte subsets between preterm (24-32 wk) and term infants [48] . The inconsistencies between studies may stem from differences in the gating strategies used during flow cytometry data analyses, because of either the inclusion or exclusion of HLA-DR staining to define the monocyte population, or because of the subjective nature of manual gating strategies.
EXPRESSION AND FUNCTION OF PATTERN RECOGNITION RECEPTORS
Monocytes are equipped with a range of pattern recognition receptors (PRRs), which are evolutionarily ancient proteins mediating the recognition of highly conserved microbial structures termed pathogen associated molecular patterns (PAMPs). PRRs may be expressed in soluble form in plasma, on the cell surface, or intracellularly within vesicles or the cytosol. Examples of cellular PRRs include the TLRs, nucleotide-binding oligomerization domain (NOD)-like receptors, retinoic acidinducible protein (RIG)-I-like receptors, and C-type lectin receptors (CLRs) [51] . CLRs recognize a variety of both self-and non-self ligands and can initiate activation or inhibition of inflammatory signaling pathways [52] . To date, no studies have directly assessed the expression of CLRs on preterm monocytes. RIG-1-like receptors are best characterized for their role in viral detection and have not been characterized in preterm infant monocytes specifically. However, cultures of mixed cord blood mononuclear cells (CBMCs) have demonstrated impaired RIG-1-dependent cytokine responses in preterm compared with term infants [53, 54] .
Most data on PRRs in preterm monocytes relate to the expression and function of TLRs, particularly TLR2 and -4, the primary receptors for recognition of Gram-positive and -negative bacteria, respectively. These investigations, however, have yielded inconsistent results ( Table 1) , with both decreased and equivalent TLR2 and -4 protein expression reported in preterm and term infant monocytes. This finding is related in part to differing experimental protocols, the GA of the preterm population studied, and limited sample sizes. In one study, Shen et al. [55] demonstrated increased basal levels of both TLR2 and -4 receptors at the mRNA level in purified monocytes of preterm infants, but decreased corresponding receptor protein levels, relative to term infants. This study highlights the difficulties in interpreting PRR function solely based on measures of gene transcripts levels. Furthermore, future studies should characterize preterm infant monocyte expression of the entire repertoire of TLRs, rather than just TLR2 and -4. CD14 and MD-2 are coreceptors for Gram-negative and -positive bacterial cell wall constituents alongside TLR2 and -4, and in fact MD-2 is required for TLR4-mediated responsiveness to LPS and enhances TLR2 responses [56] . Despite the importance of MD-2 in the monocytic response to bacteria, only one study has assessed the expression of MD-2 on preterm monocytes, and the results showed that MD-2 surface expression was significantly reduced compared to monocytes in term infants [57] . Studies on preterm monocyte surface expression of CD14 have shown a GA-dependent increase up to 32 wk (or birth weight equivalent) [58, 59] , with similar levels of expression in infants born later than 32 wk, compared with term infants [57] .
The NOD-like receptors NOD1 and -2 are expressed in the cytosol and recognize distinct structural motifs of peptidoglycan present on all Gram-positive and -negative bacteria [51] . Only one study has assessed the expression of NOD-like receptors in preterm infant monocyte subsets and reported equivalent expression of both NOD1 and -2 by preterm (27-30 wk) and term infants at both the mRNA and protein level for all 3 monocyte subsets [60] .
The general findings from PRR investigations are consistent with a pattern of an "inside-out" maturation of PRR in human preterm infants [53] , with earlier maturation of cytosolicendosomal PRR at the beginning of the third trimester of gestation, followed by maturation of extracellular receptors at mid to late gestation as proposed previously [25] . The ligation of PRRs with microbial agonists initiates specific signaling cascades that orchestrate an effective innate immune response, largely through the transcription of inflammatory cytokine and chemokine genes. These signaling pathways require the sequential phosphorylation of several downstream molecules for the activation and nuclear translocation of transcription factors [51] .
Three studies have collectively reported on the phosphorylation of 8 PRR signaling molecules by preterm monocytes in response to a wide range of stimuli (specific TLR agonists, cytokines and growth factors, and whole Gram-negative and -positive bacteria) [59, 61, 62] . Overall preterm infants display equivalent or increased phosphorylation of downstream PRR signaling molecules as early as 24 wk GA ( Table 2 ). The list of signaling molecules studied to date is not exhaustive, and it is possible that more downstream molecular components within the PRR signaling is relatively deficient at different GAs, with yet unidentified consequences.
INFLAMMATORY RESPONSES
Several studies have investigated the ability of preterm infants' monocytes to produce inflammatory cytokines and chemokines, mainly in response to various TLR agonists, but there are also more limited data on bacterial stimuli ( Table 3) . The results are somewhat conflicting, but overall, preterm monocytes appear to have an impaired ability to produce proinflammatory cytokines (TNF-a, IL-6, and IL-8). Preterm monocyte production of IL-10 and IL-12p35/p40 appears to be equivalent to term infants; however, these cytokines have only been assessed in response to LPS and findings have not been replicated [63, 64] . Almost all studies have measured the production of these cytokines at the protein level. Given that preterm monocytes display normal phosphorylation of important TLR signaling molecules [including NF-kB (49, 61) ], an impaired inflammatory protein response may be caused by a deficiency at the level of transcription or translation of the corresponding mRNA. It is also important to point out that most studies have measured monocyte cytokine responses to purified bacterial products (mainly LPS), which induce very specific signaling cascades and may be poor representatives of responses to in vivo infection.
PHAGOCYTOSIS AND KILLING MECHANISMS
The phagocytosis and subsequent degradation of bacterial pathogens is a key mechanism by which monocytes control infection [65, 66] . Collectively, investigations of the phagocytic capacity of preterm infant monocytes (with or without opsonization) have reported equivalent phagocytosis of S. epidermidis, E. coli, GBS, and Staphylococcus aureus to term infant monocytes (Table 4) . Indeed, phagocytosis appears to be one of the earliest preserved functions of monocytes maturing earlier in gestation compared to pathogen recognition-inflammasome mechanisms. Two recent studies have reported that both classic and nonclassic monocytes from preterm infants are relatively unresponsive to TLR stimulation while retaining their ability to phagocytose [48, 49] . The significance is unclear, but may be relate to maintaining a balance between protecting the fetus against potentially harmful organ effects of excessive inflammation during embryogenesis, with the demands for organ remodeling by phagocytes [67] .
Monocyte expression of CD64 (FcɛRI involved in antibodymediated phagocytosis) is similar between preterm and term infants, and even increases at the earliest GA assessed (24-31 wk; Table 5 ) [68] . However, as preterm infants exhibit efficient phagocytosis in the absence of endogenous Ig [49, [68] [69] [70] , the role of CD64 in this process may be negligible. One limitation of fluorescence-based phagocytosis assays used in these studies is the requirement to use killed bacterial preparations for effective fluorescent labeling. Development of phagocytic assays using live bacteria would provide valuable validation of these results with greater relevance to infection in vivo.
There are very limited data on the intracellular killing capacity of preterm monocytes (Table 4) . Two studies have measured the production of reactive oxygen species (superoxide) by preterm monocytes, and both report levels similar to those of term infants after stimulation with either PMA or E. coli; however, they reported conflicting findings after monocyte stimulation with N-fMLP (inducer of superoxide) [71, 72] . The study by Kaufman et al. [72] also report equivalent lysozyme release by preterm and term monocytes in response to fMLP. Recently, a third study demonstrated decreased intracellular hydrogen peroxide production in preterm infant monocytes after stimulation with propidium-iodide (PI)-labeled S. aureus, but equivalent production in response to PI-labeled E. coli [73] . Collectively, these findings indicate that preterm monocytes can produce bactericidal products; however, additional studies are needed to determine the role of these defenses in preterm infants' susceptibility to infection.
SURFACE EXPRESSION OF ANTIGEN PRESENTATION AND ADHESION MOLECULES
Whereas Mfs and dendritic cells are considered to be the predominant APCs, monocytes are equipped with machinery for antigen processing and presentation, and are capable of inducing T cell responses in the periphery [74] . Furthermore, monocytes are considered a reservoir of myeloid precursors capable of differentiating into Mf and dendritic cells during inflammation [75] . However, it has not been established whether an intrinsic monocyte defect in antigen presentation would be retained upon differentiation. Literature on the expression of molecules involved in antigen presentation has yielded inconsistent results (Table 5 ), but overall suggests that preterm monocytes exhibit reduced surface expression of HLA-DR [49, 64, 68, 70, 76] . Of these studies, only Wisgrill et al. [49] investigated HLA-DR expression on the 3 distinct monocyte subsets. The highest level of HLA-DR expression was observed on nonclassic monocytes, in contrast to adult studies where the intermediate monocyte subset displayed a higher capacity for antigen presentation (gene expression and protein surface expression of HLA-DR).
There are fewer reports on the expression of T cell costimulation molecules (CD40, CD80, and CD86) by preterm monocytes, and these are also inconsistent [64, 77, 47] . Surface expression of adhesion molecules (CD11c, CD11b, and CD18) required for monocyte migration from the periphery into inflamed tissues has generally been reported as significantly reduced on preterm monocytes (Table 5 ). These studies have assessed the expression of these molecules at the protein level by flow cytometry and differences in staining protocols or gating strategies may contribute to the inconsistency of the findings. Collectively, reduced expression of antigen presentation and costimulatory molecules may lead to an increased susceptibility to infection through a reduced capacity to induce T cell proliferation [78] .
APOPTOSIS AND INFLAMMASOME FORMATION
The clearance of apoptotic cells is important for the resolution of infection-driven inflammation [79] . Infection can also induce pyroptosis; a rapid form of cell death triggered via the formation of inflammasomes [80] . Several reports indicate that neonatal monocytes exhibit significantly reduced apoptosis following E. coli or GBS infection compared to adults, which has been associated with the up-regulated transcription of antiapoptotic proteins [81] [82] [83] . No studies have specifically investigated cell death in preterm infant monocytes; however, this would be informative, as decreased apoptosis may help explain the persistent inflammation that has been described during the neonatal period in very preterm infants [84] . One study investigated formation of the NLRP3 inflammasome in preterm monocytes (Table 2 ) [48] . Activation of the NLRP3 inflammasome is triggered via multiple PRRs and has multiple functions including the regulation of caspase-1, which is necessary for apoptotic and pyroptotic cell death, as well as production of active IL-1b [85, 86] .
Sharma et al. [48] reported a trend toward reduced NLRP3 expression with lower GA, to which they attribute the significantly reduced activation of caspase-1 observed before 29 wk GA. The primary purpose of this study was to investigate the possible mechanisms for the impaired production of IL-1b by preterm monocytes, but these results also provide the first evidence that preterm monocytes may exhibit reduced apoptosis via decreased caspase-1 expression. Caspase-1 activity increases in a gestational-dependent manner between 24 and 29 wk of GA, albeit with a high biologic variability among individuals. Given the important regulatory role of IL-1b in inflammation following oxidative stress-mediated tissue injury, heterogeneity in the maturation of caspase-1 activity during this critical gestational period may play a role determining infants' susceptibility to prematurity-related chronic lung diseases [87] .
IMPACT OF PRETERM BIRTH ON INFANT MONOCYTE PHENOTYPE AND FUNCTION
Preterm birth is driven by a range of inflammatory factors, particularly infection, which may alter the phenotype and function of monocytes at birth (detected in CB) as well as in the postnatal period and possibly beyond. There are limited data on how exposure to perinatal factors affects immune development in general and the monocyte in particular. Among potential factors, histologic chorioamnionitis (HCA) has been most studied and therefore will be discussed in detail.
Chorioamnionitis is strongly linked to preterm labor and can be detected in up to 40-70% of infants born at the lower end of GA (e.g., ,32 wk). Monocyte function in the context of HCA has been more extensively studied in animal models, particularly in sheep, which provide a more relevant model for human gestation than rodent models [88] . In ovine models, uterine inflammation is induced by LPS injection into the amniotic cavity, and lambs are delivered preterm by cesarean section. CB monocytes from preterm lambs exposed to intraamniotic LPS produce significantly lower levels of hydrogen peroxide and IL-6 on in vitro challenge with LPS, and exhibit significantly lower CD14 and MHC class II expression compared to preterm lambs without LPS exposure in utero [89, 90] . The authors attribute these observations to endotoxin tolerance, an affect that wanes over 7-14 d in animals subject to a single LPS injection. Repeated exposure to intra-amniotic LPS also had a cross-tolerance effect, attenuating the monocyte inflammatory response to TLR2, -5, and -9 agonists [91] . The down-regulation of IRAK-4 and up-regulation of IRAK-M (positive and negative regulators of TLR4 signaling respectively) by blood monocytes was also observed and was suggested to contribute to the tolerized monocyte phenotype [90, 91] .
It is important to note that after the initial period of monocyte hyporesponsiveness observed in animal studies, blood monocytes exhibited a hyper-responsive or mature phenotype by 1-2 wk, producing significantly increased levels of inflammatory cytokines and hydrogen peroxide [89] [90] [91] . In a sheep model, chronic exposure to Ureaplasma parvum (commonly isolated from human placentae affected by chorioamnionitis) also resulted in attenuated blood monocyte production of IL-6 following in vitro stimulation with LPS in preterm lambs at birth [92] . Whereas these studies may explain the association between chorioamnionitis and neonatal morbidities such as chronic lung diseases or even white matter brain injury related to a delayed proinflammatory response during the neonatal period, the clinical relevance of these effects require further studies in preterm infants.
The findings that HCA can modulate monocyte inflammatory responses in animal and cellular models have important clinical implications. Levels of inflammatory mediators in CB or CSF such as IL-6, IL-8, procalcitonin, and C-reactive protein are increased in preterm infants exposed to HCA, constituting a robust predictor of adverse preterm infant development [93] [94] [95] [96] [97] .
Exposure to HCA is also a strong risk factor for early-onset sepsis, and in contrast is associated with a decreased risk of late-onset sepsis [98] . However, the immunologic mechanisms underlying this latter observation have not been elucidated.
Two studies have assessed the effect of HCA exposure on the expression of MHC class II/HLA-DR in human preterm monocytes in CB and peripheral blood, and both demonstrated a significant reduction suggesting that HCA may result in a reduced capacity for antigen presentation [48, 93] . Other studies have failed to detect differences in PRR-stimulated responses in monocytes or mononuclear cells in infants exposed to HCA or other relevant perinatal factors, including exposure to antenatal corticosteroids or the presence of labor [53, 99] . More investigations of the effects of perinatal factors on postnatal monocyte function and phenotype are needed (using larger cohorts of infants) to understand the impact of preterm birth on early life susceptibility to infectious and inflammatory diseases.
POTENTIAL ROLE OF EPIGENETICS AND IMMUNE TRAINING DURING DEVELOPMENT
Recent evidence suggests that epigenetic variation, during normal development or upon exposure to perinatal factors, may play a role regulating monocyte function during development [100] . Bermick et al. [100] reported GA-dependent regulation of the histone modifications H3K4me3 and H3K4me1 in neonatal monocytes, both of which affect promoter sites of important immune genes (IL1B, IL6, IL12B, TNF, and CCR2).
They observed an increase in activating H3K4me3 on these promoter sites (but no change in H3K4me1) as infants approached term, suggesting that the ratio of H3K4me3/ H3K4me1 may profoundly affect monocyte maturity and immune function in preterm infants. The authors postulate that increased H3K4me3 deposition in monocytes during postnatal development is prompted by stimuli within the ex utero environment, and that these changes effectively "remodel the epigenetic landscape of the monocytes to a more mature and functional state." Although infants exposed to HCA were excluded in this study, these findings warrant investigation into the potential epigenetic changes associated with prenatal exposure to infection and inflammation, and their putative persistent effects on susceptibility to infection. More recently, substimulatory doses of PRR agonists have been shown to trigger epigenetic changes in human monocytes, but also in other innate immune cells leading to a heightened response to restimulation following a period of rest [101] . This phenomenon, originally term "innate immune training" by Netea [102] , is particularly strongly induced through stimulation of the CLR dectin-1 by b-1,3-glucan. This phenomenon is potentially of major clinical relevance to preterm infants as well, because b-1,3-glucan is a primary constituent of the cell of several micro-organisms including Candida, a commensal fungus that is ubiquitously present in the environment. This notion raises the possibility that immune training plays an important role in the maturation of innate immune functions during the postnatal period. Although the concept of immune training has been validated in human adults following Bacille Calmette-Guerin (BCG) vaccination [103] , further studies are needed in neonates to determine how pre-or postnatal exposure to microbes may affect preterm infants' tolerance to subsequent infections.
CONCLUSIONS AND FUTURE PERSPECTIVES
In summary, monocytes from preterm infants born early in the third trimester of gestation exhibit attenuated proinflammatory cytokine responses after whole bacterial or specific ligand stimulation, despite comparable levels of bacterial phagocytosis and phosphorylation of downstream pattern recognition receptor signaling pathways. Most studies have assessed these parameters at the protein level by using a small subset of selected immune mediators. More comprehensive systems-based investigation incorporating genomewide transcriptomic or epigenetic measures would be valuable to determine the mechanisms underlying the impairment in proinflammatory cytokine production. In addition, studies using live sepsis-causing bacterial pathogens would be more aligned with in vivo conditions. Whole bacterial challenge is more clinically relevant, capturing immune responses to the entire repertoire of PAMP-PRR interactions, rather than the discrete signaling pathways initiated by single PRR-agonists. A consistent limitation of many studies investigating monocytes in preterm infants is the lack of subset profiling. There is evidence that monocyte subsets are functionally distinct in adults, and this information may be critical for putting findings into proper biologic context. Comprehensive assessment of the potentially divergent functions of monocyte subsets in neonates could evaluate GA-dependent and other variations and provide a more nuanced understanding of monocyte development and function. Finally, there is a major knowledge gap in understanding how prenatal exposure to HCA affects monocyte development and function. This deficit is important, given the high incidence of HCA among preterm deliveries and the associated link between HCA exposure and a differential risk of neonatal and childhood infection and other inflammation-related outcomes.
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